247 related articles for article (PubMed ID: 10698600)
21. Linear growth response to exogenous growth hormone in Prader-Willi syndrome.
Lee PD; Wilson DM; Rountree L; Hintz RL; Rosenfeld RG
Am J Med Genet; 1987 Dec; 28(4):865-71. PubMed ID: 3688024
[TBL] [Abstract][Full Text] [Related]
22. Sudden death in growth hormone-treated children with Prader-Willi syndrome.
Van Vliet G; Deal CL; Crock PA; Robitaille Y; Oligny LL
J Pediatr; 2004 Jan; 144(1):129-31. PubMed ID: 14722532
[TBL] [Abstract][Full Text] [Related]
23. Growth hormone therapy in Prader-Willi syndrome.
Davies PS
Int J Obes Relat Metab Disord; 2001 Jan; 25(1):2-7. PubMed ID: 11244451
[No Abstract] [Full Text] [Related]
24. [Growth hormone therapy].
Krysiak R; Okopień B; Gdula-Dymek A
Pol Merkur Lekarski; 2007 Apr; 22(130):305-11. PubMed ID: 17684932
[TBL] [Abstract][Full Text] [Related]
25. Body composition in Prader-Willi syndrome: assessment and effects of growth hormone administration.
Davies PS
Acta Paediatr Suppl; 1999 Dec; 88(433):105-8. PubMed ID: 10626557
[TBL] [Abstract][Full Text] [Related]
26. Growth hormone therapy in children with Prader-Willi syndrome.
Franzese A; Romano A; Spagnuolo MI; Ruju F; Valerio G
J Pediatr; 2006 Jun; 148(6):846; author reply 846-7. PubMed ID: 16769405
[No Abstract] [Full Text] [Related]
27. KIGS highlights: growth hormone treatment in Prader-Willi Syndrome.
Tauber M; Cutfield W
Horm Res; 2007; 68 Suppl 5():48-50. PubMed ID: 18174707
[No Abstract] [Full Text] [Related]
28. Endocrine dysfunction in Prader-Willi syndrome: a review with special reference to GH.
Burman P; Ritzén EM; Lindgren AC
Endocr Rev; 2001 Dec; 22(6):787-99. PubMed ID: 11739333
[TBL] [Abstract][Full Text] [Related]
29. Prader-Willi syndrome: who can have growth hormone?
Stafler P; Wallis C
Arch Dis Child; 2008 Apr; 93(4):341-5. PubMed ID: 18089632
[TBL] [Abstract][Full Text] [Related]
30. Effect of 6 months of growth hormone treatment in young children with Prader-Willi syndrome.
Eiholzer U; Weber R; Stutz K; Steinert H
Acta Paediatr Suppl; 1997 Nov; 423():66-8. PubMed ID: 9401543
[TBL] [Abstract][Full Text] [Related]
31. Five-years growth hormone (GH) treatment in adults with Prader-Willi syndrome.
Höybye C
Acta Paediatr; 2007 Mar; 96(3):410-3. PubMed ID: 17407467
[TBL] [Abstract][Full Text] [Related]
32. Growth hormone and respiratory compromise in Prader-Willi Syndrome.
Wilson SS; Cotterill AM; Harris MA
Arch Dis Child; 2006 Apr; 91(4):349-50. PubMed ID: 16551791
[TBL] [Abstract][Full Text] [Related]
33. Retrospective study of the potential benefits and adverse events during growth hormone treatment in children with Prader-Willi syndrome.
Fillion M; Deal C; Van Vliet G
J Pediatr; 2009 Feb; 154(2):230-3. PubMed ID: 18814886
[TBL] [Abstract][Full Text] [Related]
34. Clinical effects of treatment for hypogonadism in male adolescents with Prader-Labhart-Willi syndrome.
Eiholzer U; Grieser J; Schlumpf M; l'Allemand D
Horm Res; 2007; 68(4):178-84. PubMed ID: 17374959
[TBL] [Abstract][Full Text] [Related]
35. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
Högler W; Briody J; Moore B; Lu PW; Cowell CT
Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
[TBL] [Abstract][Full Text] [Related]
36. [The influence of long-term growth hormone replacement therapy on body composition, bone tissue and some metabolic parameters in adults with growth hormone deficiency].
Olsovská V; Siprová H; Beránek M; Soska V
Vnitr Lek; 2005 Dec; 51(12):1356-64. PubMed ID: 16430102
[TBL] [Abstract][Full Text] [Related]
37. Five years of growth hormone treatment in children with Prader-Willi syndrome. Swedish National Growth Hormone Advisory Group.
Lindgren AC; Ritzén EM
Acta Paediatr Suppl; 1999 Dec; 88(433):109-11. PubMed ID: 10626558
[TBL] [Abstract][Full Text] [Related]
38. [Prader-Willi syndrome. Treatment with growth hormone in 2 cases].
Youlton R
Rev Med Chil; 2001 Oct; 129(10):1186-90. PubMed ID: 11775347
[TBL] [Abstract][Full Text] [Related]
39. Growth hormone therapy for children and adolescents with Prader-Willi syndrome is associated with improved body composition and metabolic status in adulthood.
Coupaye M; Lorenzini F; Lloret-Linares C; Molinas C; Pinto G; Diene G; Mimoun E; Demeer G; Labrousse F; Jauregi J; Laurier V; Basdevant A; Polak M; Thuilleaux D; Tauber M; Poitou C
J Clin Endocrinol Metab; 2013 Feb; 98(2):E328-35. PubMed ID: 23284006
[TBL] [Abstract][Full Text] [Related]
40. Sudden death in Prader-Willi syndrome: brief review of five additional cases. Concerning the article by U. Eiholzer et al.: Deaths in children with Prader-Willi syndrome. A contribution to the debate about the safety of growth hormone treatment in children with PWS (Horm Res 2005;63:33-39).
Bakker B; Maneatis T; Lippe B
Horm Res; 2007; 67(4):203-4. PubMed ID: 17164585
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
